Wuxi PharmaTech is looking to relist its biologic arm in Hong Kong after the group was taken private through a management buyout in late 2015.
Chinese private hospital operator launches Asia’s first IPO in the new calendar year.
Chinese hydropower company sells euro and dollar exchangeable bonds, defying a stock price slump in Hong Kong.
Chris Gammons will now run Bank of America’s global capital markets team in Asia Pacific.
Datang Environment, FIT Hon Teng and Shanghai Dazhong look to raise over $1 billion from listings in November. For investors, they offer a change after a run of financial IPOs.
The second biggest IPO of a blockbuster year in India prices its anchor tranche at the top of the indicative range. It reflects strong interest in the country's residential property sector.
After the successful deal, China Resources Group has now listed six of its subsidiaries in Hong Kong.
China's second-largest drug manufacturer to raise funds for expansion amid industry consolidation.
First class stamp for China; second class outcome for institutional investors from world's biggest IPO of the year.
India's largest life insurer completes the country's biggest flotation in six years.
The SFC’s new enforcer has been clearing the decks on long-running investigations. That's a wise move — he can now move on to bigger, tough-to-tackle problems.
Similar to other state-owned banks, the post-to-banking lender’s Hong Kong listing is yet another deal dominated by investment from state institutions.
Chinese lender attracts strong order book and responds with aggressive spread tightening.
Postal Savings Bank of China, China’s largest banking by retail network, has begun gauging investor interest for its mammoth $8 billion Hong Kong listing.
US insurer ended 13 years of stock ownership in PICC’s property and casualty arm by executing its fourth block sale on Saturday.
Malaysian state fund continues its track record of regular sukuk issuance, printing yet another bond exchangeable into shares of Beijing Enterprises Water Group.
British insurer Prudential and Taiwan’s Mercuries Life Insurance are among eight cornerstone investors in the Chinese brokerage’s $1.2 billion H-share offering.
The Shanghai-based brokerage gauges market demand for a Hong Kong share sale that has been delayed since the beginning of the year.
Rare opportunity to access pure sovereign credit brings US investors to the forefront.
The state investment fund's move to take SMRT private follows the publication of a new rail ownership framework.